Department of Immuno-Oncology, Peking University, Beijing 100871, China
Brief Report
FGFR Signaling: A Target for Cholangiocarcinoma Treatment
Author(s): Jia Li*
Journal of Oncology Medicine & Practice received 142 citations as per Google Scholar report